Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: EMERGINGDX INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-08-22 to 2026-03-21
Current total value of award: $249969.13
Description: SMALL BUSINESS INNOVATIVE RESEARCH PHASE I, PROPOSAL H252-001-0018, TITLED: INTEGRATED MULTIPLEXED LOW-COST DIAGNOSTIC PLATFORM FOR RAPID MICROBIAL IDENTIFICATION, MEDICAL RESEARCH AND DEVELOPMENT CONTRACT.